Immuron Ltd current report, Q1 FY2018

Business Context and Reporting Period

Immuron Limited, a foreign private issuer based in Australia, filed this Form 6-K on March 16, 2018. The filing reports on a corporate action announced to the Australian Securities Exchange on the same date regarding a private placement of securities.

Key Financial Metrics

The filing discloses the completion of a private placement to a US Fund totaling A$5.1 million. The document does not provide specific figures for revenue, profit, cash flow, operating margins, existing debt levels, or overall liquidity ratios for the reporting period.

Material Changes

The primary material change reported is the successful completion of the A$5.1 million capital raise. This transaction represents an increase in the company's equity capital and cash resources, though the specific impact on diluted share count or immediate balance sheet changes is detailed in the attached exhibits rather than the summary text.

Guidance, Outlook, and Risks

The filing text does not contain management commentary on future guidance, operational outlook, or specific risk factors. The document serves primarily as a regulatory notification of the placement and includes an Appendix 3B and Section 708A Notice Disclosure as exhibits.

Investor Verification Checklist

  • Verify the exact number of shares issued in the A$5.1 million placement and the issue price per share.
  • Review the attached Appendix 3B (Exhibit 99.2) for details on the use of proceeds and the identity of the US Fund.
  • Confirm the impact of this placement on the company's total issued share capital and potential dilution to existing shareholders.
  • Check the Section 708A Notice (Exhibit 99.3) for any specific conditions or restrictions attached to the placement.